anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Problem Agitate Solution

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 26,550
Current window 20,941-20,970
Pages 885
Rows per page 30
Arc: Problem Agitate Solutionclear collectionreset all
18 30 60

Arc

20,941-20,970 of 26,550

filter-aware
31
The table includes sub-categorization of completed treatments by severity levels.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
32
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
33
Includes three distinct charts: a line chart for PK over time, a scatter plot for PK/PD correlation, and a box plot for IRAK4 levels.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
34
Data represents Part C: 75 mg QD (fed). Error bars represent standard error (SE).Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
35
The chart uses a dotted horizontal line to indicate the baseline level of healthy subjects for visual comparison.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
36
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
37
The slide highlights that all reported adverse events were mild (except one severe headache) and all patients recovered.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
38
Data presented as mean change from baseline with 90% CI. n=9 for MAD3 and n=20 for Part C (n=19 for day 14).Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
39
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
40
The slide uses a grouped bar chart format to compare efficacy across three cohorts for two different stimulation conditions (LPS and R848).Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
41
The chart specifically tracks IL-6 levels over 42 days.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
42
The slide uses individual patient IDs on the y-axis and log2 fold change on the x-axis to visualize gene expression changes.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
43
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
44
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
45
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
46
Includes error bars representing standard error of the mean.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
47
Data presented as line charts with error bars representing standard error or confidence intervals.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
48
The chart tracks 7 patients over time, showing a shift from severe/moderate to mild categories.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
49
Includes clinical photography, efficacy endpoint table, and biomarker data (cytokines and RNAseq).Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
50
The slide uses a comparison table to highlight the efficacy of KT-474 against external benchmarks.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
51
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
52
Data compares 'All HS' vs 'Moderate to Severe' patient cohorts. Includes error bars representing standard error or 80% confidence intervals.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
53
The chart displays response rates for 'All HS' and 'Moderate to Severe' cohorts with 80% confidence intervals.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
54
Data presented as line charts with error bars for two patient cohorts.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
55
The chart displays longitudinal clinical trial data with error bars representing standard error of the mean.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
56
The charts track patient status from baseline to day 42. The left chart includes 12 patients, the right chart includes 10 patients.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
57
The slide uses a before-after framework to demonstrate clinical efficacy.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
58
Includes patient demographics, clinical efficacy table, before/after photos, and a line chart of cytokine/reactant levels.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
59
The slide uses a comparison table to highlight efficacy metrics across different clinical endpoints.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
60
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit